RohitBishnoiMD

PubMed

• 208 citations
  Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
  Petros Grivas, Ali Raza Khaki, Trisha Wise-Draper, Benjamin French, C. Hennessy, Chih-Yuan Hsu, Yu Shyr, X. Li, Toni K. Choueiri, Corrie A. Painter, Solange Peters, Br...> ;Annals of Oncology. 2021 Jun 1
• 2 citations
  A Multi-Center Retrospective Analysis Examining the Effect of Dipeptidyl Peptidase-4 Inhibitors on Progression-Free Survival in Patients With Prostate Cancer.
  Kelsey Pan, William Paul Skelton, Mohammed Elzeneini, Thu-Cuc Nguyen, Aaron J Franke, Azka Ali, Rohit Bishnoi, Long Dang, Nam H. Dang, Julie A. Kish> ;Cureus. 2021 Apr 27
• 24 citations
  Real-world experience of carfilzomib-associated cardiovascular adverse events: SEER-Medicare data set analysis.
  Rohit Bishnoi, Zhigang Xie, Chintan Shah, Jian-Guo Bian, Hemant S. Murthy, John R. Wingard, Nosha Farhadfar> ;Cancer Medicine. 2021 Jan 1
• 2 citations
  Utilization Pattern of Computed Tomographic Colonography in the United States: Analysis of the U.S. National Health Interview Survey.
  Young-Rock Hong, Zhigang Xie, Kea Turner, Santanu K. Datta, Rohit Bishnoi, Chintan Shah> ;Cancer Prevention Research. 2021 Jan 1
• 2 citations
  Reduction of immunosuppression for post-transplant lymphoproliferative disorder (PTLD): a single-center experience of allograft survival outcomes.
  Kelsey Pan, Aaron J Franke, William Paul Skelton, Rohit Bishnoi, Chintan Shah, Nam H. Dang, Kawther F. Alquadan> ;Leukemia & Lymphoma. 2021 Apr 16
• 22 citations
  A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;Cancer Cell. 2020 Dec 14
• 8 citations
  Cardiovascular toxicity in patients treated with immunotherapy for metastatic non-small cell lung cancer: A SEER-medicare study: CVD outcomes with the use of ICI in mN...
  Rohit Bishnoi, Chintan Shah, Anne H. Blaes, Jian-Guo Bian, Young-Rock Hong> ;Lung Cancer. 2020 Nov 3
• 17 citations
  Predicting in-hospital mortality of patients with febrile neutropenia using machine learning models
  Xinsong Du, Jae Min, Chintan Shah, Rohit Bishnoi, William R. Hogan, Dominick J. Lemas> ;International Journal of Medical Informatics. 2020 Jul 1
• 1183 citations
  Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
  Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera, Sanjay Shete, Chih-Yuan Hsu, Aakash Desai, Gilberto Lopes, Petros G...> ;Lancet. 2020 Jun 20
• 4 citations
  Post Transplant Lymphoproliferative Disorder risk factors in children: Analysis of a 23‐year single‐institutional experience
  Raphael C. Bosse, Aaron J Franke, William Paul Skelton, Lindsey E. Woody, Rohit Bishnoi, Yu Wang, Dhanashree Rajderkar, Renata Shih, Nam H. Dang, William B. Slayton, S...> ;Pediatric Transplantation. 2020 Aug 1
• Bleeding and Thrombotic Risk in Low Dose Heparin Infusion as Compared to Standard Dose Heparin Infusion.
  Forat Lutfi, Rohit Bishnoi, Vikas J Patel, Aisha Elfasi, Michael Setteducato, Shuyao Zhang, Chintan Shah, Saji Kurian, Chethana Kamath, Dae Jun Kim, Marc Zumberg, Mart...> ;Cureus. 2020 May 28
• 20 citations
  Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer.
  Chintan Shah, Young-Rock Hong, Rohit Bishnoi, Azka Ali, William Paul Skelton, Long H. Dang, Jinhai Huo, Nam H. Dang> ;Frontiers in Oncology. 2020 Mar 31
• 1 citations
  Utilization of Antineoplastic Agents and Medicare Spending in Elderly Patients With Extensive-Stage Small-Cell Lung Cancer Between 2001 and 2013.
  Chintan Shah, Young-Rock Hong, Rohit Bishnoi, Dennie V. Jones, Jinhai Huo> ;JCO Oncology Practice. 2020 Feb 19
• 4 citations
  Single-institution Retrospective Analysis of Prognostic Factors Influencing Very Late-onset Post-transplant Lymphoproliferative Disorder.
  Rohit Bishnoi, Jordan M Minish, Aaron J Franke, William Paul Skelton, Chintan Shah, Yu Wang, Nam H. Dang> ;Cureus. 2020 Feb 7
• 32 citations
  Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and En...
  Rohit Bishnoi, Young-Rock Hong, Chintan Shah, Azka Ali, William Paul Skelton, Jinhai Huo, Nam H. Dang, Long H. Dang> ;Cancer Medicine. 2019 Jul 1
• 20 citations
  Survival trends of metastatic small intestinal neuroendocrine tumor: a population-based analysis of SEER database.
  Chintan Shah, Lazarus K. Mramba, Rohit Bishnoi, Athira Unnikrishnan, Jennifer M. Duff, Sreenivasa R Chandana> ;Journal of Gastrointestinal Oncology. 2019 May 24
• 11 citations
  Analysis of Overall Survival in Patients With Multiple Primary Malignancies: A Single-center Experience.
  William Paul Skelton, Azka Ali, Michelle N. Skelton, Roland A Federico, Raphael C. Bosse, Thu-Cuc Nguyen, Long H. Dang, Rohit Bishnoi> ;Cureus. 2019 Apr 27
• 3 citations
  An innovative resident-driven mortality case review curriculum to teach and drive system-based practice improvements in the United States
  Nila S. Radhakrishnan, Margaret C. Lo, Rohit Bishnoi, Subhankar Samal, Robert Leverence, Eric I. Rosenberg, Zareen Zaidi> ;Journal of Educational Evaluation for Health Professions. 2018 Dec 26
• 20 citations
  A multi‑center retrospective analysis of the effect of DPP4 inhibitors on progression‑free survival in advanced airway and colorectal cancers
  Azka Ali, Alejandra C. Fuentes, William Paul Skelton, Yu Wang, Susan P. McGorray, Chintan Shah, Rohit Bishnoi, Long H. Dang, Nam H. Dang> ;Molecular and Clinical Oncology. 2018 Nov 13
• 22 citations
  The role of a best practice alert in the electronic medical record in reducing repetitive lab tests.
  Harini Bejjanki, Lazarus K. Mramba, Stacy G. Beal, Nila S. Radhakrishnan, Rohit Bishnoi, Chintan Shah, Nikhil Agrawal, Neil S. Harris, Robert Leverence, Kenneth H. Rand> ;Clinicoeconomics and Outcomes Research. 2018 Oct 8
• 13 citations
  Efficacy and safety of carfilzomib in relapsed and/or refractory multiple myeloma: systematic review and meta-analysis of 14 trials.
  Chintan Shah, Rohit Bishnoi, Yu Wang, Fei Zou, Harini Bejjanki, Samip Master, Jan S. Moreb> ;Oncotarget. 2018 May 4
• 57 citations
  Cardiotoxicity associated with carfilzomib: systematic review and meta-analysis
  Chintan Shah, Rohit Bishnoi, Ankur Jain, Harini Bejjanki, Sican Xiong, Yu Wang, Fei Zou, Jan S. Moreb> ;Leukemia & Lymphoma. 2018 Feb 21
• 8 citations
  Stereotactic body radiation therapy for the treatment of oligoprogression on androgen receptor targeted therapy in castration-resistant prostate cancer.
  Thu-Cuc Nguyen, Ravneet Bajwa, Shahla Bari, Azka Ali, William Paul Skelton, Roland-Austin Federico, Rohit Bishnoi, Justin Wray, Robert A. Zlotecki, Long H. Dang, Jamee...> ;Oxford Medical Case Reports. 2018 Jan 1
• 1 citations
  Novel Mutation Pair L858M/L861Q Caused Resistance to Both First- and Third-Generation EGFR Inhibitors, but Was Found to Be Sensitive to the Combination of Lapatinib an...
  Harini Bejjanki, Rohit Bishnoi, David Reisman> ;Journal of Thoracic Oncology. 2017 Oct 1
• 27 citations
  Survival differences among patients with hepatocellular carcinoma based on the stage of disease and therapy received: pre and post sorafenib era.
  Chintan Shah, Lazarus K. Mramba, Rohit Bishnoi, Harini Bejjanki, Hardik Satish Chhatrala, Sreenivasa R Chandana> ;Journal of Gastrointestinal Oncology. 2017 Oct 1
• Join now to see all

Lectures

• DDP4 inhibitors as novel agents in improving survival in diabetic patients with CRC and lung cancer: A SEER-Medicare study. 
  2019 ASCO Annual Meeting - 6/1/2019
• Bleeding and Thrombotic Risk in Low Dose Heparin Infusion As Compared to Standard Dose Heparin Infusion 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018